This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Eli Lilly and Co (LLY)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 3.83B 4.02B 5.92B 5.99B
Receivables 4.02B 3.89B 4.24B 4.16B
Inventories 2.93B 2.64B 2.30B 2.52B
Other Current Assets 0.00 822.30M 0.00 0.00
Total Current Assets 13.10B 13.04B 14.25B 14.84B
Property, Plant & Equipment, Gross 15.65B 14.92B 14.59B 14.49B
Accumulated Depreciation & Depletion 7.67B 7.16B 6.83B 6.55B
Property, Plant & Equipment, Net 7.98B 7.76B 7.76B 7.94B
Intangibles 2.81B 3.25B 3.69B 3.39B
Other Non-Current Assets 9.84B 8.85B 6.52B 3.40B
Total Non-Current Assets 22.14B 21.36B 19.41B 16.16B
Liabilities & Shareholder Equity
Total Assets 35.25B 34.40B 33.66B 31.00B
Accounts Payable 1.12B 1.19B 1.13B 1.07B
Short Term Debt 1.01B 11.90M 1.52B 156.00M
Other Current Liabilities 5.05B 5.20B 3.71B 5.02B
Total Current Liabilities 8.92B 8.39B 8.93B 7.10B
Long Term Debt 4.20B 5.52B 5.46B 6.77B
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 4.49B 5.72B 5.73B 4.72B
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 8.70B 11.24B 11.19B 11.48B
Total Liabilities 17.62B 19.63B 20.12B 18.58B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 17.63B 14.77B 13.54B 12.42B
Common Par 0.00 716.60M 0.00 0.00
Additional Paid In Capital 5.75B 4.96B 5.61B 5.52B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 16.99B 16.09B 14.90B 12.73B
Treasury Stock -93.60M -192.40M -95.30M -96.40M
Other Equity Adjustments -5.02B -6.81B -6.87B -5.74B
Total Capitalization 21.83B 20.28B 19.01B 19.19B
Total Equity 17.63B 14.77B 13.54B 12.42B
Total Liabilities & Stock Equity 35.25B 34.40B 33.66B 31.00B
Total Common Shares Outstanding 1.12B 1.15B 1.16B 1.15B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 833.00K 2.85M 853.00K 864.00K
Basic Weighted Shares Outstanding 1.08B 1.11B 1.11B 1.11B
Diluted Weighted Shares Outstanding 1.08B 1.12B 1.11B 1.11B
Number of Employees 37925 38350 38080 38350
Number of Part-Time Employees 0 0 0 0
LLY News

LLY Eli Lilly and Co

Analysts Ratings for LLY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 5 5 5
Moderate Buy 0 0 0 0
Hold 8 8 8 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 2
GET LLY ANALYST REPORT

Brokerage Partners

LLY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs